Halozyme (HALO) Debt/EBITDA US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 0.19 0.52 3.62 3.62 2.57   1.47  
Changes by years, y/y, % -42% +174% +591% 0% -29%     -4.8%

Halozyme. Debt/EBITDA

Halozyme. Debt/EBITDA, changes, %

Halozyme (HALO) Debt/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA 2.57 2.63 2.19 1.97 1.47   1.47
Changes by years, y/y, % -39% -28% -44% -35% -43%    
Changes by quarters, q/q, % -15% +2% -16% -10% -25%    

Halozyme. Debt/EBITDA

Halozyme. Debt/EBITDA, changes, y/y, %

Halozyme. Debt/EBITDA, changes, q/q, %